These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31543192)

  • 21. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis.
    Kuznetsova T; Staessen JA; Wang JG; Gasowski J; Nikitin Y; Ryabikov A; Fagard R
    J Hum Hypertens; 2000 Jul; 14(7):447-54. PubMed ID: 10918550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
    Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
    Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.
    Osono E; Kurihara S; Hayama N; Sakurai Y; Ohwada K; Onoda N; Takeuchi M; Tomizawa T; Komaba Y; Hashimoto K; Matsunobu S; Yoneshima H; Iino Y
    Am J Kidney Dis; 1998 Nov; 32(5):725-30. PubMed ID: 9820440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele.
    Prasad N; O'Kane KP; Johnstone HA; Wheeldon NM; McMahon AD; Webb DJ; MacDonald TM
    QJM; 1994 Nov; 87(11):659-62. PubMed ID: 7820539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between genotype of angiotensin converting enzyme gene and left ventricular hypertrophy in Chinese hypertensives].
    Shen D; Ha D; Bai C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):364-6. PubMed ID: 9845769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiotensin-converting enzyme polymorphism on aortic elastic parameters in athletes.
    Tanriverdi H; Evrengul H; Kaftan A; Dursunoglu D; Turgut S; Akda B; Kiliç M
    Cardiology; 2005; 104(3):113-9. PubMed ID: 16088128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women].
    Orłowska-Baranowska E; Placha G; Gaciong Z; Zakrzewski D; Baranowski R; Kuśmierczyk-Droszcz B; Hoffman P; Rawczyńska-Englert I
    Pol Arch Med Wewn; 2002 Sep; 108(3):855-66. PubMed ID: 12600182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients.
    Nagahara T; Ishigami T; Sano T; Ikeda Y; Hibi K; Uneda S; Umemura S; Ishii M
    Jpn Heart J; 1997 Nov; 38(6):821-30. PubMed ID: 9486935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.
    Palmer BR; Pilbrow AP; Yandle TG; Frampton CM; Richards AM; Nicholls MG; Cameron VA
    J Am Coll Cardiol; 2003 Mar; 41(5):729-36. PubMed ID: 12628714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The polymorphism of the angiotensin-converting enzyme gene in patients with hypertension, left ventricular hypertrophy and the development of a myocardial infarct at a young age. Preliminary report].
    Moiseev VS; Demurov LM; Kobalava ZhD; Chistiakov DA; Tereshchenko SN; Kondrat'ev IaIu; Korovina EA; Nosikov VV
    Ter Arkh; 1997; 69(9):18-23. PubMed ID: 9411819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure.
    Andersson B; Sylvén C
    J Am Coll Cardiol; 1996 Jul; 28(1):162-7. PubMed ID: 8752809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; McFadden E; Lablanche JM; Bertrand M; Amouyel P
    Heart; 1997 Jun; 77(6):502-5. PubMed ID: 9227291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men.
    López-Contreras J; Blanco-Vaca F; Borrás X; Carreras F; Pons-Lladó G; Gallego F; Solé MJ; Cirera S; Benet MT; Negredo E; Roca-Cusachs A
    J Hum Hypertens; 2000 May; 14(5):327-31. PubMed ID: 10822320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACE I/D polymorphism and cardiac adaptations in adolescent athletes.
    Rizzo M; Gensini F; Fatini C; Manetti P; Pucci N; Capalbo A; Vono MC; Galanti G
    Med Sci Sports Exerc; 2003 Dec; 35(12):1986-90. PubMed ID: 14652492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.